Literature DB >> 6704042

Ototoxic effect of erythromycin therapy.

V G Schweitzer, N R Olson.   

Abstract

Thirty-two cases of sudden, symmetrical, high-frequency, sensorineural hearing loss associated with intravenous (IV) and oral erythromycin therapy have been published since 1973. We treated a patient with reversible ototoxicity associated with IV erythromycin for the treatment of legionnaire's disease.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6704042     DOI： 10.1001/archotol.1984.00800300050011

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN： 0003-9977


  9 in total

1.  Effect of age on single- and multiple-dose pharmacokinetics of erythromycin.

Authors:  P A Miglioli; P Pivetta; M Strazzabosco; R Orlando; L Okolicsanyi; P Palatini
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Sensorineural hearing loss with low dose erythromycin.

Authors:  E Kemp; S Keidar; J G Brook
Journal:  BMJ       Date:  1991-06-01

Review 3.  [Central nervous system side effects of different antibacterial substances].

Authors:  G Stoppe; E Rüther
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 4.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 5.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

6.  Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.

Authors:  E Wolinsky; C R Horsburgh; D L Cohn; R B Roberts; H Masur; R Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

Review 7.  Experimental, clinical and preventive aspects of ototoxicity.

Authors:  A A Chiodo; P W Alberti
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 8.  Adverse effects of macrolide antibacterials.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 9.  Ototoxicity of Non-aminoglycoside Antibiotics.

Authors:  Leonard P Rybak; Vickram Ramkumar; Debashree Mukherjea
Journal:  Front Neurol       Date:  2021-03-09       Impact factor: 4.003
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.